Gielda Papierow Wartosciowych w Wrszw : CLNPHARMA (Communiqué)
December 05, 2016 at 11:19 am EST
Share
2016-12-05 17:13:15
Warsaw, December 5, 2016
Communiqué
(GPW Main List)
The Warsaw Stock Exchange (GPW) announces that based on the Management Board resolutions no. 42/2007, as amended, following the trading session on December 5, 2016 there will be an extraordinary adjustment and 15,000,000 shares of CLNPHARMA company (ISIN PLCLNPH00015) will supplement WIG and WIG-Poland indices.
CLNPHARMA company's shares were introduced to trading on the GPW Main List on December 1, 2016 and fulfill free float criteria of the above mentioned indices.
WSE - Warsaw Stock Exchange SA published this content on 05 December 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 05 December 2016 16:19:06 UTC.
Original documenthttps://www.gpw.pl/komunikaty_en/?ph_tresc_glowna_start=show&ph_tresc_glowna_cmn_id=59489
Public permalinkhttp://www.publicnow.com/view/F52AEAE6BD17209803461898DD7D8415F8EA556D
Gielda Papierow Wartosciowych w Warszawie SA (Warsaw Stock Exchange, GPW) is a Poland-based stock exchange. It is a parent entity of WSE Group that offers products and services within its trading markets of equity, derivate, fixed income and structured products. It also distributes market data. The Company has two business lines: Financial market, which includes trading in equities, derivatives, fixed-income and other instruments, listing, and information services; and Commodity market, which includes trading in electricity and property rights in certificates of origin, operation of a register of certificates of origin, clearing, trade and technical trade operator services. As of December 31, 2011, it operates two wholly owned subsidiaries, WSEInfoEngine SA, providing data transmission and information services; and Instytut Rynku Kapitalowego WSE Research SA, engaged in publishing; as well as 92.47%-owned BondSpot SA.
GIELDA PAPIERÓW WARTOSCIOWYCH W WARSZAWIE S.A. 
